Windlas Biotech Limited (NSE:WINDLAS)
India flag India · Delayed Price · Currency is INR
1,002.95
+8.75 (0.88%)
Aug 29, 2025, 3:30 PM IST

Windlas Biotech Statistics

Total Valuation

Windlas Biotech has a market cap or net worth of INR 20.87 billion. The enterprise value is 18.80 billion.

Market Cap20.87B
Enterprise Value 18.80B

Important Dates

The last earnings date was Monday, August 11, 2025.

Earnings Date Aug 11, 2025
Ex-Dividend Date Jul 21, 2025

Share Statistics

Windlas Biotech has 20.90 million shares outstanding. The number of shares has increased by 1.42% in one year.

Current Share Class 20.90M
Shares Outstanding 20.90M
Shares Change (YoY) +1.42%
Shares Change (QoQ) +0.04%
Owned by Insiders (%) 62.51%
Owned by Institutions (%) 9.06%
Float 7.83M

Valuation Ratios

The trailing PE ratio is 32.46.

PE Ratio 32.46
Forward PE n/a
PS Ratio 2.63
PB Ratio 4.13
P/TBV Ratio 4.18
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 28.84
EV / Sales 2.37
EV / EBITDA 18.32
EV / EBIT 26.66
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.06
Debt / EBITDA 0.32
Debt / FCF n/a
Interest Coverage 14.25

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 8.89%
Return on Capital Employed (ROCE) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count1,154
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Windlas Biotech has paid 195.25 million in taxes.

Income Tax 195.25M
Effective Tax Rate 23.05%

Stock Price Statistics

The stock price has increased by +18.95% in the last 52 weeks. The beta is 0.28, so Windlas Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.28
52-Week Price Change +18.95%
50-Day Moving Average 947.79
200-Day Moving Average 964.19
Relative Strength Index (RSI) 53.33
Average Volume (20 Days) 104,657

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Windlas Biotech had revenue of INR 7.95 billion and earned 651.79 million in profits. Earnings per share was 30.76.

Revenue7.95B
Gross Profit 3.03B
Operating Income 705.28M
Pretax Income 847.04M
Net Income 651.79M
EBITDA 1.03B
EBIT 705.28M
Earnings Per Share (EPS) 30.76
Full Income Statement

Balance Sheet

The company has 2.39 billion in cash and 325.97 million in debt, giving a net cash position of 2.07 billion or 98.90 per share.

Cash & Cash Equivalents 2.39B
Total Debt 325.97M
Net Cash 2.07B
Net Cash Per Share 98.90
Equity (Book Value) 5.06B
Book Value Per Share 241.38
Working Capital n/a
Full Balance Sheet

Cash Flow

Operating Cash Flow n/a
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 38.08%, with operating and profit margins of 8.87% and 8.20%.

Gross Margin 38.08%
Operating Margin 8.87%
Pretax Margin 10.66%
Profit Margin 8.20%
EBITDA Margin 12.91%
EBIT Margin 8.87%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of 5.80, which amounts to a dividend yield of 0.58%.

Dividend Per Share 5.80
Dividend Yield 0.58%
Dividend Growth (YoY) 5.45%
Years of Dividend Growth 3
Payout Ratio n/a
Buyback Yield -1.42%
Shareholder Yield -0.84%
Earnings Yield 3.12%
FCF Yield n/a
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2